Logo image of BSX.DE

BOSTON SCIENTIFIC CORP (BSX.DE) Stock Analyst Ratings

Europe - FRA:BSX - US1011371077 - Common Stock

87.8 EUR
-1.8 (-2.01%)
Last: 10/24/2025, 7:00:00 PM
Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to BSX.DE. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 108.53. This target is 23.61% above the current price.
BSX.DE was analyzed by 41 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about BSX.DE.
In the previous month the buy percentage consensus was at a similar level.
BSX.DE was analyzed by 41 analysts, which is quite many. So the average rating should be quite meaningful.
BSX.DE Historical Analyst RatingsBSX.DE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -106 -96 -86 -76 -66 -56 -46 -36 -26 -16 -6 10 20 30 40

Price Target & Forecast

Price Low Median Mean High 87.8087.87109.60108.53126.37 - 0.09% 24.83% 23.61% 43.93%
BSX.DE Current Analyst RatingBSX.DE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15 20
Up and Down Grades
Date Firm Action Rating
2021-07-28 Raymond James Maintains Strong Buy
2021-07-28 Credit Suisse Maintains Outperform
2021-07-28 Morgan Stanley Maintains Overweight
2021-05-26 Needham Downgrade Buy -> Hold
2021-05-25 Barclays Initiate Overweight
2021-04-29 Morgan Stanley Maintains Overweight
2021-04-15 Atlantic Equities Initiate Overweight
2021-02-12 Needham Maintains Buy

BOSTON SCIENTIFIC CORP / BSX.DE FAQ

What is the average price target for BOSTON SCIENTIFIC CORP (BSX.DE) stock?

41 analysts have analysed BSX.DE and the average price target is 108.53 EUR. This implies a price increase of 23.61% is expected in the next year compared to the current price of 87.8.


What is the consensus rating for BOSTON SCIENTIFIC CORP (BSX.DE) stock?

The consensus rating for BOSTON SCIENTIFIC CORP (BSX.DE) is 86.3415 / 100 . This indicates that analysts generally have a positive outlook on the stock.